Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Prometheus Announces New Findings Regarding Patients At Risk For Celiac Disease At DDW
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced new findings regarding a correlation between an important serologic marker used in the detection of Crohn"s disease and particular genetic markers in patients at risk for celiac disease. In an oral presentation yesterday at Digestive Disease Week (DDW) in Chicago, Prometheus reported a statistically significant correlation between antibodies to the flagellin CBir1 and HLA haplotypes DQ2.5 and DQ8 in a study of 5,406 patients at risk for celiac disease who are EMA positive. Blood and serum samples were analyzed using PROMETHEUS(R) Celiac PLUS and PROMETHEUS(R) IBD Serology 7 diagnostic tests.

Caldera Medical Announces FDA Clearance Of Novel Treatment For Pelvic Organ Prolapse
Caldera Medical, Inc. announced that it has received FDA clearance and CE Mark certification for the Ascend Pelvic Floor Repair System with Apical Support, a novel treatment for female pelvic organ prolapse. Ascend® is the latest addition to the Caldera Medical family of products designed to treat female stress urinary incontinence (SUI) and pelvic organ prolapse (POP). Caldera"s product line includes the Desara® Sling System, a universal sling that allows surgeons their choice of multiple surgical approaches by utilizing reusable instrumentation. Caldera is the only U.S. company offering this unique solution, which benefits surgeons, hospitals, and the environment.
News of the day
Secretary Sebelius Releases Inaugural Health Care "Success Story" Report
HHS Secretary Kathleen Sebelius released the first in a series of health care "success story" reports that document innovative programs and initiatives that can serve as models for a reformed American health care system. The inaugural report highlights the Michigan Keystone ICU Project. A joint partnership between the Michigan Health & Hospital Association and the Johns Hopkins University, the Michigan Keystone ICU Project helped dramatically reduce the number of health care associated infections in Michigan, saving over 1,500 lives and $200 million.
Medical Devices

The European Association For The Study Of The Liver Renews Publishing Partnership With Elsevier

Elsevier, the leading publisher of scientific, technical and medical information, is pleased to announce its renewed publishing partnership with The European Association for the Study of the Liver (EASL), the leading European association in the field of liver research. The agreement calls for Elsevier to publish the society"s flagship journal, the Journal of Hepatology, for the next five years. EASL is a society with over 1500 members. The society has given rise to a significant number of international clinical trials and research collaborations in liver disease for the benefit of patients all over the world. EASL"s flagship journal - the Journal of Hepatology - requires high standard quality contents and is highly perceived in its field. The journal publishes original papers, reviews, case reports and letters to the editor concerned with clinical and basic research in the field of hepatology. "I am thankful to work with a professional learned society and also very grateful for its support and input over the last years. I look forward to working with the newly appointed Editor-in-Chief, Professor Didier Samuel and his editorial team. The management and cure of, for instance, infectious liver diseases like Hepatitis B and C as well as the advanced search for the basic mechanisms of liver failure are major and global challenges of the 21st century. Elsevier is confident to make the Journal of Hepatology a continuing and growing success for authors, readers and for EASL" commented Koos Admiraal MD, Publisher for Elsevier. Koos Admiraal Elsevier


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009